Prognosis

Pfizer to Submit Data to FDA on Fourth Covid Shot Soon, CEO Says

WATCH: Pfizer Chairman and CEO Albert Bourla discusses his new book “Moonshot,” and progress on developing a fourth Covid-19 booster. Source: Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Riley Griffin

March 8, 2022 at 6:15 PM UTC

This article is for subscribers only.

Pfizer Inc. will soon submit data to U.S. regulators on a fourth dose of its Covid-19 vaccine, Chief Executive Officer Albert Bourla said.

Bourla said he spent Tuesday morning reviewing new data from various Covid vaccine studies, including one looking at the effects of a fourth dose of the currently available vaccine, as well as a new formulation that will protect against multiple coronavirus variants.